Obesity in India is a chronic disease, not a personal failure, requiring empathy, science-based treatment, and public health strategies.

A new study reveals that bariatric surgery results in significantly greater weight loss compared to popular GLP-1 drugs.

Eli Lilly's Zepbound is the first and only approved dual GLP-1/GIP agonist, and Lilly is also working on its own triple ...

Scholar Rock (NASDAQ:SRRK) announced Wednesday that its lead candidate, apitegromab, in combination with Eli Lilly’s ...

Around 1.5 million Brits are now taking weight-loss drugs, such as Mounjaro, and pharmacists are warning users to be careful in the heatwave ...

Curious about Mitolyn? We dug through Mitolyn supplement reviews to reveal the truth—no fluff, just facts. Here's what worked and what didn't ...

The side effects of taking Mounjaro can be very varied, and the drug tends to affect people differently. The most common side effects include feeling sick, diarrhoea, constipation, vomiting, heartburn ...

In a statement, a spokesperson for Ozempic manufacturer Novo Nordisk only said that the company has “been working closely with policymakers in Pennsylvania” to ensure continued access ...

This study adds to the growing evidence that while GLP-1 medications can be helpful for some patients, bariatric surgery remains the most powerful option for substantial and lasting weight ...

Research symposia focus on new combinations and medication formulations for both obesity and type 2 diabetes, as well as new ...

TLC aired 1000-Lb Sisters Season 7 Episode 9 on June 17, 2025. The latest episode of the reality show featured a nostalgic ...